High Value Preventive Care During COVID-19
Special focus on immunizations
Biosimilars in the Pharmacy Benefit
Despite the fact that less than 2% of the US population uses biologic drugs, they account for 26% of national prescription drug spending. Biosimilars can expand options, enhance affordability, and increase access to therapy.
Cannabis Products on the Formulary
Adhering to evidence-based and value-based standards.
Hospital Payment Strategies
Setting Price and Quality Expectations
Advancing the Employers Role in Healthcare Quality and Safety
Removing Barriers to Postpartum Depression Care
Confronting a Misunderstood and Undermanaged Workforce Disease
A Fresh Look at Benefit Design Considerations
Putting Care Back in the Hands of Doctors and Patients
Accelerating Action for Parity and Peak Performance